Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,794.00    14.00 (0.79%)
Bid:
1,787.00
Ask:
1,789.00
Spread: 2.00 (0.112%)
Market Cap: £3.52b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Year End Trading Update

28 Aug 2025 07:00

RNS Number : 9365W
Softcat PLC
28 August 2025
 

28 August 2025

Softcat plc

Year End Trading Update

 

Softcat plc ("Softcat", or the "Group"), a leading UK provider of IT infrastructure technology and services, today publishes a trading update (unaudited) for the financial year ended 31 July 2025.

 

Following the update provided on 28 May, the Group continued to trade well during the fourth quarter, supported by further conversion of larger solutions projects. As a result, the Board now expects to deliver high-teens growth in full year gross profit and mid-teens growth in operating profit1. The Group also remains highly cash generative, with FY2025 cash conversion2 expected to be towards the top end of our guided range of 85%-95%.

 

Looking ahead, Softcat remains well positioned to deliver further growth. Excluding the significant incremental contribution from large projects in FY2025, the Board expects to deliver low double-digit gross profit growth and high single-digit operating profit growth in FY20263. Including the significant incremental contribution from large deals in the comparative period, this translates to reported rates of high single-digit gross profit growth and low single-digit growth in operating profit.

 

Softcat's FY2025 preliminary results are scheduled for release on 22 October 2025.

 

 

1 Full year operating profit adjusted to remove non-underlying items, including acquisition-related expenses such as the fair value of deferred contingent consideration, and implementation costs of the new sales system. FY2025 guidance remains on a consistent basis with that provided in previous statements.

2 Cash conversion adjusted to remove the impact of non-underlying items and acquisition-related cash flows.

3Operating profit excluding the significant incremental contribution from large deals in FY2025 is c.£170m.

 

For further information, please contact:

Softcat plc

Graham Charlton, Chief Executive Officer + 44 (0)1628 403 610

Katy Mecklenburgh, Chief Financial Officer

Michael Watts, Head of Investor Relations

 

Media Enquiries ‐ FTI Consulting LLP

Ed Bridges/Matt Dixon + 44 (0)20 3727 1000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLRTSIDFIE
Date   Source Headline
15th Jan 20265:29 pmRNSTransaction in Own Shares
14th Jan 20265:35 pmRNSTransaction in Own Shares
13th Jan 20265:29 pmRNSTransaction in Own Shares
12th Jan 20265:33 pmRNSTransaction in Own Shares
9th Jan 20266:21 pmRNSTransaction in Own Shares
8th Jan 20266:31 pmRNSTransaction in Own Shares
8th Jan 20262:03 pmRNSDirector/PDMR Shareholding
8th Jan 20267:00 amRNSShare Buyback Programme
2nd Jan 202610:21 amRNSTotal Voting Rights
22nd Dec 202512:25 pmRNSDirector/PDMR Shareholding
22nd Dec 202512:25 pmRNSDirector/PDMR Shareholding
16th Dec 20251:15 pmRNSResult of AGM
15th Dec 20254:02 pmRNSDirector/PDMR Shareholding
12th Dec 20251:06 pmRNSDirector/PDMR Shareholding
10th Dec 202511:18 amRNSDirector/PDMR Shareholding
10th Dec 202511:09 amRNSDirector/PDMR Shareholding
28th Nov 20251:47 pmRNSDirector/PDMR Shareholding
28th Nov 20251:41 pmRNSDirector/PDMR Shareholding
25th Nov 202510:43 amRNSAdditional Listing
18th Nov 20257:00 amRNSQ1 2026 Trading Update
13th Nov 202511:04 amRNSBlock listing Interim Review
11th Nov 20252:29 pmRNSDirector/PDMR Shareholding
5th Nov 20251:15 pmRNSAnnual Financial Report
3rd Nov 20252:37 pmRNSTotal Voting Rights
22nd Oct 20257:00 amRNSPreliminary Results
9th Oct 20252:48 pmRNSDirector/PDMR Shareholding
23rd Sep 202510:57 amRNSHolding(s) in Company
9th Sep 20251:46 pmRNSDirector/PDMR Shareholding
28th Aug 20257:00 amRNSYear End Trading Update
11th Aug 20258:48 amRNSDirector/PDMR Shareholding
9th Jul 20259:24 amRNSDirector/PDMR Shareholding
1st Jul 20259:21 amRNSTotal Voting Rights
10th Jun 20253:07 pmRNSDirector/PDMR Shareholding
2nd Jun 20254:30 pmRNSTotal Voting Rights
28th May 20257:00 amRNSQ3 2025 Trading Update
27th May 20259:14 amRNSDirector Declaration
15th May 20259:39 amRNSBlock listing Interim Review
9th May 202512:58 pmRNSDirector/PDMR Shareholding
1st May 20253:41 pmRNSTotal Voting Rights
8th Apr 20252:46 pmRNSDirector/PDMR Shareholding
7th Apr 20259:00 amRNSAcquisition of Oakland Group Services Ltd
1st Apr 202511:35 amRNSTotal Voting Rights
19th Mar 20257:00 amRNSHalf-year Report
13th Mar 20259:52 amRNSHolding(s) in Company
10th Mar 20252:13 pmRNSDirector/PDMR Shareholding
3rd Mar 202510:41 amRNSTotal Voting Rights
26th Feb 20257:00 amRNSNotice of Results
10th Feb 20252:37 pmRNSDirector/PDMR Shareholding
3rd Feb 20259:53 amRNSTotal Voting Rights
21st Jan 20251:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.